Living to 120? Drug trials to begin on humans next year

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

It’s a drug used to treat people with type 2 diabetes. But could Metformin become the world’s first anti-aging medication?

Scientists believe the drug — which is a common, inexpensive medication used to control the sugar levels of those with type 2 diabetes — could extend the human lifespan by several decades. They believe some people taking the drug could live into their 120s.

According to The Telegraph, researchers have already proven that the drug extends the life of animals. The Food and Drug Administration has given the go ahead for trials to begin on humans in 2016.

The Telegraph also reported that scientists from a range of institutions are currently raising funds and recruiting 3,000 70 to 80-year-olds who have, or are at risk of cancer, heart disease, and dementia. They are hoping to show that drug slows the aging process and stops disease.

To read more about the study, click here.